Tex. Ins. Code § 1575.159

Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.

Section 1575.159 - Coverage for Prostate-Specific Antigen Test

A health benefit plan offered under the group program, other than a Medicare Advantage plan or a Medicare prescription drug plan, must provide coverage for a medically accepted prostate-specific antigen test used for the detection of prostate cancer for each male enrolled in the health benefit plan who:

(1) is at least 50 years of age; or

(2) is at least 40 years of age and:

(A) has a family history of prostate cancer; or

(B) exhibits another cancer risk factor.

Tex. Ins. Code § 1575.159

Amended by Acts 2017, Texas Acts of the 85th Leg. - Regular Session, ch. 712,Sec. 13, eff. 9/1/2017.

Added by Acts 2001, 77th Leg., ch. 1419, Sec. 3, eff. 6/1/2003.

See Acts 2017, Texas Acts of the 85th Leg. - Regular Session, ch. 712, Sec. 25.